Ultimately, us as individual investors are the "idiots" I guess. I figure Jenkins probably joined the BOD for Archer just because he is friends with Mullan. Who knows, maybe so he can write-off a vacation to the Sarasota area. Again, as I have said many times of this board, worth keeping an eye on where Mullan/Jenkins land ultimately in terms of anything that attempts to leverage anatabine even in an ancillary way. Perhaps they are "guiltless" with respect to RCPI failures, but IMO, they made some very questionable decisions in terms of driving the company into the ground.
Market Data 
Markets 
AI
